Anxiety and Related Sleep Disorders - Malaysia

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$32.23m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.10%, resulting in a market volume of US$32.39m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$16.60 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in Malaysia is experiencing steady growth due to increasing customer preferences for natural and holistic remedies, as well as the rising awareness of mental health issues in the country.

Customer preferences: Customers in Malaysia are increasingly seeking natural and holistic remedies for anxiety and sleep disorders. This shift in preference can be attributed to the growing awareness of the potential side effects and dependency issues associated with pharmaceutical drugs. Many consumers are now opting for herbal supplements and alternative therapies, such as acupuncture and aromatherapy, to manage their symptoms. This preference for natural remedies is driving the demand for herbal and natural products in the Anxiety and Related Sleep Disorders market.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in Malaysia is the increasing use of CBD (cannabidiol) products. CBD is a non-psychoactive compound derived from the cannabis plant, and it has been found to have potential therapeutic effects for anxiety and sleep disorders. The growing acceptance and legalization of CBD products in Malaysia has led to a surge in demand for CBD-based treatments. This trend is expected to continue as more research is conducted on the benefits of CBD for anxiety and sleep disorders.Another trend in the market is the rising popularity of sleep aids and supplements. With the hectic and stressful lifestyles of many Malaysians, sleep disorders are becoming increasingly common. As a result, there is a growing demand for products that can help improve sleep quality and promote relaxation. Sleep aids such as melatonin supplements and herbal teas are gaining popularity among consumers looking for natural solutions to their sleep problems.

Local special circumstances: Malaysia has a diverse population with a mix of different cultures and traditions. Traditional medicine, such as traditional Chinese medicine (TCM) and traditional Malay medicine (TMM), plays a significant role in the healthcare system. Many Malaysians have a long-standing trust in traditional remedies and are more likely to seek out traditional treatments for anxiety and sleep disorders. This preference for traditional medicine has created a niche market for traditional herbal remedies and therapies in the Anxiety and Related Sleep Disorders market.

Underlying macroeconomic factors: The growing awareness of mental health issues and the increasing prevalence of anxiety and sleep disorders are driving the growth of the Anxiety and Related Sleep Disorders market in Malaysia. The fast-paced and competitive nature of modern life, coupled with the impact of the COVID-19 pandemic, has contributed to a rise in stress levels and mental health problems among Malaysians. This has created a greater demand for products and services that can help alleviate anxiety and improve sleep quality.In conclusion, the Anxiety and Related Sleep Disorders market in Malaysia is experiencing steady growth due to increasing customer preferences for natural and holistic remedies, the rising popularity of CBD products, and the growing demand for sleep aids and supplements. The local special circumstances, such as the preference for traditional medicine, also contribute to the development of the market. The underlying macroeconomic factors, including the growing awareness of mental health issues and the impact of the COVID-19 pandemic, further drive the growth of the market.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.